Since 2011, we’ve taken a unique, decentralized approach, operating in many regions to ensure that our machine learning algorithms provide accurate detection of rare and challenging cases, analyzing data in a way that reflects many diverse populations around the world. In turn, one million genomic profiles analyzed allows researchers globally to benefit from more precise, real-world data analysis, furthering the capabilities of data-driven medicine.
To mark the occasion, our coworkers celebrated on multiple continents from our various offices and headquarters including Switzerland, France and Boston, MA and more joined remotely through video chats. We asked our peers what this accomplishment means to them and here’s what some of them had to say:
When I started six years ago, SOPHiA GENETICS was just starting to be known in the market, and now we are a key player in it.
The community is growing and with more analyses, SOPHiA GENETICS AI becomes more robust and smarter. We are now unlocking new ways to help researchers.
It is incredible that we have impacted so many people, bringing them solutions to their real problems. Clients needed results, experts needed support and we have been there, close to them, doing our best!
This is what we come to work for every day, no matter which department or role.
It brings purpose to my job, being able to say that our efforts have now touched the lives of so many.
I don’t know how many companies that have had the pleasure of achieving such a huge goal.
Looking forward to celebrate the two million!
Check out the photos of our celebrations below and contact us if you’d like to learn more about the SOPHiA DDM™ Platform.
